BIOMAT Database Logo BIOMAT Database Logo

Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis. 1997

R M Nagra, and B Becher, and W W Tourtellotte, and J P Antel, and D Gold, and T Paladino, and R A Smith, and J R Nelson, and W F Reynolds
Neurology Research Service, West Los Angeles VA Medical Center and Brain Research Institute, CA 90073, USA.

The myeloperoxidase enzyme (MPO) is expressed specifically in myeloid cells and catalyzes the formation of hypochlorous acid and other cytotoxic oxidants. We previously reported that two alleles of MPO exist which differ in promoter strength due to a base difference in an Alu-encoded hormone response element. The present study shows that the higher expressing MPO genotype is overrepresented in early onset multiple sclerosis in females, implicating MPO in this demyelinating disease. Contrary to the general conception that macrophages lack MPO, immunohistochemical analysis shows that MPO is present in microglia/macrophages in and around MS lesions as shown by colocalization with major histocompatibility antigens HLA-DR and phagocytized myelin. Also, MPO mRNA sequences are detected in cDNA derived from isolated human adult microglia. This is the first evidence that MPO is present in microglia/macrophages at MS lesions, that MPO gene expression occurs in microglia and that MPO plays a role in MS pathogenesis as shown by the allelic disequilibrium in early onset disease.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D009195 Peroxidase A hemeprotein from leukocytes. Deficiency of this enzyme leads to a hereditary disorder coupled with disseminated moniliasis. It catalyzes the conversion of a donor and peroxide to an oxidized donor and water. EC 1.11.1.7. Myeloperoxidase,Hemi-Myeloperoxidase,Hemi Myeloperoxidase
D005260 Female Females
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

R M Nagra, and B Becher, and W W Tourtellotte, and J P Antel, and D Gold, and T Paladino, and R A Smith, and J R Nelson, and W F Reynolds
A screen of candidates from peaks of linkage: evidence for the involvement of myeloperoxidase in multiple sclerosis.
August 1999, Journal of neuroimmunology,
R M Nagra, and B Becher, and W W Tourtellotte, and J P Antel, and D Gold, and T Paladino, and R A Smith, and J R Nelson, and W F Reynolds
Involvement of Genetic Factors in Multiple Sclerosis.
January 2020, Frontiers in cellular neuroscience,
R M Nagra, and B Becher, and W W Tourtellotte, and J P Antel, and D Gold, and T Paladino, and R A Smith, and J R Nelson, and W F Reynolds
Genetic variation in the myeloperoxidase gene and cognitive impairment in multiple sclerosis.
February 2006, Journal of negative results in biomedicine,
R M Nagra, and B Becher, and W W Tourtellotte, and J P Antel, and D Gold, and T Paladino, and R A Smith, and J R Nelson, and W F Reynolds
The etiology of multiple sclerosis: genetic evidence for the involvement of the human endogenous retrovirus HERV-Fc1.
February 2011, PloS one,
R M Nagra, and B Becher, and W W Tourtellotte, and J P Antel, and D Gold, and T Paladino, and R A Smith, and J R Nelson, and W F Reynolds
Elevated myeloperoxidase activity in white matter in multiple sclerosis.
October 2008, Neuroscience letters,
R M Nagra, and B Becher, and W W Tourtellotte, and J P Antel, and D Gold, and T Paladino, and R A Smith, and J R Nelson, and W F Reynolds
Lack of evidence for involvement of known human retroviruses in multiple sclerosis.
January 1986, Nature,
R M Nagra, and B Becher, and W W Tourtellotte, and J P Antel, and D Gold, and T Paladino, and R A Smith, and J R Nelson, and W F Reynolds
Low leucocyte myeloperoxidase activity in patients with multiple sclerosis.
July 2003, Journal of neurology, neurosurgery, and psychiatry,
R M Nagra, and B Becher, and W W Tourtellotte, and J P Antel, and D Gold, and T Paladino, and R A Smith, and J R Nelson, and W F Reynolds
Respiratory involvement in multiple sclerosis.
April 1992, Brain : a journal of neurology,
R M Nagra, and B Becher, and W W Tourtellotte, and J P Antel, and D Gold, and T Paladino, and R A Smith, and J R Nelson, and W F Reynolds
Retinal involvement in multiple sclerosis.
October 2007, Neurology,
R M Nagra, and B Becher, and W W Tourtellotte, and J P Antel, and D Gold, and T Paladino, and R A Smith, and J R Nelson, and W F Reynolds
[Auditory involvement in multiple sclerosis].
June 1978, Journal francais d'oto-rhino-laryngologie; audiophonologie, chirurgie maxillo-faciale,
Copied contents to your clipboard!